**Data has been sanitized and meant for Illustrative purposes only
Needed to evaluate the Asian market for the product
acceptance of Nanotechnology based cardiac
diagnostic platform, in which they were considering
to invest for commercialization of the technology in
Asian and other markets
Aagami involved a team of a senior and a junior
Analyst to conduct primary and secondary research
on cardiovascular disease and its diagnosis in Asia.
Parameters such as drawbacks of prevailing diagnosis
methods & details of actual time taken by General
practitioners , were studied, documented and
Enumerated the benefits of using Nanoplasmonic
tech – MI in cardiovascular, cancer & HIV.
Collated the key market trends in East & South Asia
and highlighted the key findings in tabular &
graphical presentation for quick analysis.
Prepared a concise report on the addressable and
product acceptance for the new Technology in
Cardiac Diagnostic market
Client found the report effective and helpful. The key
market trends & insights provided, served as
conclusive guidance to the client for finalizing
further investment into the technology and preparing
Market entry and Pricing strategy for Asian market.
Investors Controlled Innovative technology company